<p>(A) Tumor-growth curve. The tumor volume in mice injected with MDA-MB-231 cells expressing VEGFR-1-shRNA was significantly smaller than the control. *<i>P</i><0.05. (B) Immunohistochemical analysis of EMT related regulators in tumor sections. VEGFR-1 down-regulation in xenografts resulted in up-regulation of E-cadherin expression, with down-regulation of N-cadherin and Snail expression. (magnification: 400×). (C) <i>In vivo</i> imaging analysis. Mice treated with MDA-MB-231/shNC (a) had cervical metastasis; however, the mice treated with MDA-MB-231/VEGFR-1 shRNA (b) exhibited no observable metastasis. The reporter used GFP to show the metastasis.</p
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
Vascular endothelial growth factor (VEGF) performs as an angiogenic and permeability factor in ovari...
Purpose: Tumor associated angiogenesis and/or lymphangiogenesis are known to be linked by VEGFR sign...
<p>(<b>A</b>) The growth of xenograft tumors initiated by GSLCs with or without VEGFR-2 shRNA. * Ind...
<p>a. MB-MDA-231 breast cancer cells were grown as xenografts in female nude mice for 2 weeks prior ...
Vascular endothelial growth factor receptor-1 (VEGFR-1 or Flt-1), a tyrosine kinase receptor, is hig...
<p>A. Lysates from 786-O cells stably expressing VHL, the SCR or the VEGF shRNAs were prepared and a...
Vascular endothelial growth factor receptor-1 (VEGFR-1 or Flt-1), a tyrosine kinase receptor, is hig...
The role of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) in tumor metastasis remains ...
The role of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) in tumor metastasis remains ...
<p>(A) Western blot analysis of VEGFR-1 expression in MDA-MB-231 and MCF-7 cells transfected with a ...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
Resistance to anti-angiogenic therapy can occur via several potential mechanisms. Unexpectedly, rece...
The vascular endothelial growth factor (VEGF) family members, VEGF-A, placenta growth factor (PlGF),...
The effect of blocking VEGF activity in solid tumors extends beyond inhibition of angiogenesis. Howe...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
Vascular endothelial growth factor (VEGF) performs as an angiogenic and permeability factor in ovari...
Purpose: Tumor associated angiogenesis and/or lymphangiogenesis are known to be linked by VEGFR sign...
<p>(<b>A</b>) The growth of xenograft tumors initiated by GSLCs with or without VEGFR-2 shRNA. * Ind...
<p>a. MB-MDA-231 breast cancer cells were grown as xenografts in female nude mice for 2 weeks prior ...
Vascular endothelial growth factor receptor-1 (VEGFR-1 or Flt-1), a tyrosine kinase receptor, is hig...
<p>A. Lysates from 786-O cells stably expressing VHL, the SCR or the VEGF shRNAs were prepared and a...
Vascular endothelial growth factor receptor-1 (VEGFR-1 or Flt-1), a tyrosine kinase receptor, is hig...
The role of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) in tumor metastasis remains ...
The role of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) in tumor metastasis remains ...
<p>(A) Western blot analysis of VEGFR-1 expression in MDA-MB-231 and MCF-7 cells transfected with a ...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
Resistance to anti-angiogenic therapy can occur via several potential mechanisms. Unexpectedly, rece...
The vascular endothelial growth factor (VEGF) family members, VEGF-A, placenta growth factor (PlGF),...
The effect of blocking VEGF activity in solid tumors extends beyond inhibition of angiogenesis. Howe...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
Vascular endothelial growth factor (VEGF) performs as an angiogenic and permeability factor in ovari...
Purpose: Tumor associated angiogenesis and/or lymphangiogenesis are known to be linked by VEGFR sign...